Yagi et al., 2016 - Google Patents
Diagnostic accuracy of neuropsychological tests for classification of dementia.Yagi et al., 2016
- Document ID
- 10922256581783797791
- Author
- Yagi T
- Ito D
- Sugiyama D
- Iwasawa S
- Tabuchi H
- Konishi M
- Araki M
- Saitoh N
- Nihei Y
- Mimura M
- Suzuki N
- Publication year
- Publication venue
- Neurology Asia
External Links
Snippet
Although numerous studies have shown that each neuropsychological test is effective for diagnosing mild cognitive impairment (MCI) or Alzheimer's disease (AD), studies comparing diagnostic accuracies of various neuropsychological tests are relatively rare and practical …
- 238000010855 neuropsychological testing 0 title abstract description 32
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Milani et al. | Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity | |
Bondi et al. | Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates | |
Rascovsky et al. | Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD | |
Wallin et al. | The Gothenburg MCI study: design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up | |
Freitas et al. | Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia | |
Lin et al. | Insula and inferior frontal gyrus’ activities protect memory performance against Alzheimer’s disease pathology in old age | |
Gallagher et al. | Mild cognitive impairment, screening, and patient perceptions in heart failure patients | |
Bartos et al. | Validation of the czech montreal cognitive assessment for mild cognitive impairment due to Alzheimer disease and czech norms in 1,552 elderly persons | |
Ueki et al. | Factors associated with mortality in patients with early‐onset Alzheimer's disease: a five‐year longitudinal study | |
Naik et al. | Diagnosing dementia‐ICD‐10 not so bad after all: a comparison between dementia criteria according to DSM‐IV and ICD‐10 | |
Roy et al. | Preliminary investigation of cognitive function in aged multiple sclerosis patients: challenges in detecting comorbid Alzheimer’s disease | |
Wood et al. | Montreal Cognitive Assessment (MoCA) performance and domain-specific index scores in amnestic versus aphasic dementia | |
Hsiao et al. | Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment | |
Devlin et al. | Heterogeneity of neuropsychological impairment in HIV infection: contributions from mild cognitive impairment | |
Yagi et al. | Diagnostic accuracy of neuropsychological tests for classification of dementia. | |
desRosiers et al. | The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression | |
Rosca et al. | Montreal cognitive assessment for evaluating cognitive impairment in Huntington’s disease: A systematic review | |
Shim et al. | Literacy independent cognitive assessment: assessing mild cognitive impairment in older adults with low literacy skills | |
Thomas et al. | Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer’s disease | |
Darby et al. | Episodic memory decline predicts cortical amyloid status in community-dwelling older adults | |
Hicks et al. | Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for Alzheimer’s dementia | |
Seubert-Ravelo et al. | Mild cognitive impairment in patients with early-onset Parkinson's disease | |
Eliassen et al. | Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer’s pathology and progression to dementia. | |
Vogel et al. | Frequency and severity of semantic deficits in a consecutive memory clinic cohort | |
Younes et al. | Internet-based cognitive testing in multiple sclerosis |